Suchergebnisse - "Antoniadou, Anastasia"

PubPharm (218)

51

Validation of molecular clock inferred HIV infection ages : Evidence for accurate estimation of infection dates

enthalten in: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases | 2021

von Kostaki, E. | Limnaios, S. | Roussos, S. | +10

52

COMPARATIVE IMMUNOGENICITY OF BNT162b2 mRNA VACCINE WITH NATURAL COVID-19 INFECTION

enthalten in: bioRxiv.org | 2021

von Psichogiou, M. | Karabinis, A. | Poulakou, G. | +23

53

Risk of congenital cytomegalovirus infection in children born to women with IgG avidity in the grey zone during first trimester of pregnancy

enthalten in: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians | 2021

von Kekkou, K. | Kavatha, D. | Karalexi, M. | +4

54

No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL

enthalten in: Journal of the International AIDS Society | 2021

von Atkinson, A. | Miro, J. | Mocroft, A. | +15

55

Earlier treatment initiation is associated with a decreased number of HIV-1 subtype A1 transmissions in Greece

enthalten in: Sexually transmitted infections | 2021

von Kostaki, E. | Hodges-Mameletzis, I. | Magiorkinis, G. | +24

56

Coronavirus disease 2019 pandemic in Greece, February 26 - May 3, 2020 : The first wave

enthalten in: Travel medicine and infectious disease | 2021

von Maltezou, H. | Papadima, K. | Gkolfinopoulou, K. | +22

57

A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis

enthalten in: Microorganisms | 2021

von Pappa, V. | Bouchla, A. | Terpos, E. | +27

58

Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria : relevance to external validity

enthalten in: BMC infectious diseases | 2021

von Daitch, V. | Paul, M. | Daikos, G. | +27

59

Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity

enthalten in: BMC infectious diseases | 2021

von Daitch, V. | Paul, M. | Daikos, G. | +27

60

Siblings with coronavirus disease 2019 infection and opposite outcome-the hemodialysis's better outcome paradox : Two case reports

enthalten in: World journal of nephrology | 2021

von Bacharaki, D. | Chrysanthopoulou, E. | Grigoropoulou, S. | +9